Orchid Pharma Ltd.

ORCHPHARMA

₹843.5

3.98% (32.3)

Market Cap

₹4,282 Cr.

P/E

38.82

About

Orchid Pharma is a vertically integrated pharmaceutical company with expertise in research, manufacturing, and marketing. They have a strong presence in various therapeutic segments and offer a wide r… Read more

Orchid Pharma is a vertically integrated pharmaceutical company with expertise in research, ma… Read more

Low

684

52W Range

High

1997

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

7 Yes

Positive for this company

3 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Other Income

Other income component is making ratios of the company look optically better

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
ROE

Financial leverage has increased roe over 10 years
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up - Geography Wise

Peer Comparison

FAQs on Orchid Pharma Ltd. Business

What does Orchid Pharma do?

Orchid Pharma is a vertically integrated pharmaceutical company with expertise in research, manufacturing, and marketing. They offer a wide range of pharmaceutical solutions and have a global presence through strategic alliances.

Who are the competitors of Orchid Pharma?

Orchid Pharma major competitors are Unichem Lab, Sequent Scientific, Gufic Biosciences, Guj. Themis Biosyn, Panacea Biotec, Zota Health Care, Indoco Remedies.
Market Cap of Orchid Pharma is ₹4,113 Crs.
While the median market cap of its peers are ₹3,338 Crs.

Is Orchid Pharma financially stable compared to its competitors?

Orchid Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep	Sep Dec
Investor Presentation		Mar Jun Sep Dec	Jun Sep Dec	Mar Jun Aug Sep Dec	Mar Sep Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Sep	Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Orchid Pharma Ltd.

View The Discussion On Valuepickr

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Orchid Pharma Ltd.